Validating artificial intelligence effectiveness defined Lung nodule malignancy score in patients with pulmonary nodule.

Trial Identifier: D133FR00178
Sponsor: AstraZeneca
NCTID:: NCT05817110
Start Date: April 2023
Primary Completion Date: April 2026
Study Completion Date: April 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations